Grants and Contributions:
Title:
Development of recombinant diagnostic enzymes
Agreement Number:
934376
Agreement Value:
$250,000.00
Agreement Date:
Sep 1, 2019 - Aug 31, 2020
Description:
Development of recombinant enzymes that are used for clinical chemistry tests.
Process development for manufacturing recombinant diagnostic enzymes
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Richmond, British Columbia, CA V6V 2J2
Reference Number:
172-2019-2020-Q2-934376
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
818615684
Recipient Type:
For-profit organization
Recipient's Legal Name:
SignalChem Lifesciences Corporation
Federal Riding Name:
Steveston--Richmond East
Federal Riding Number:
59031
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710